정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
---|---|---|---|---|---|---|---|---|---|---|---|
58 | Not yet recruiting | Urine Alkalinisation in COVID-19 | Acute Kidney Injury | Drug: Sodium bicarbonate Drug: standard care |
Not Applicable | Guy's and St Thomas' NHS Foundation Trust, University of Pittsburgh | OTHER | 80 | All | 18 Years | |
57 | Recruiting | Urine Alkalinisation to Prevent AKI in COVID-19 | Covid19 | Drug: Sodium Bicarbonate 150Meq/L/D5W Inj | Phase 3 | Guy's and St Thomas' NHS Foundation Trust | OTHER | 80 | All | 18 Years | Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom |
56 | Not yet recruiting | Use of a Live Attenuated Vaccine as an Immune-based Preventive Against COVID-19-associated Sepsis | Sepsis Syndrome | Biological: MMR vaccine | Phase 3 | Louisiana State University Health Sciences Center in New Orleans, Parsemus Foundation | OTHER | 60 | All | 18 Years ~ 70 Years | |
55 | Completed | Use of Angiotensin-(1-7) in COVID-19 | Respiratory Failure | Drug: Angiotensin-(1-7) Drug: Placebo |
Phase 2 | Erasme University Hospital, Federal University of Minas Gerais, Angitec, Fonds Erasme pour la Recherche Medicale | OTHER | 112 | All | 17 Years ~ 81 Years | Hospital Eduardo de Menezes, Belo Horizonte, Minas Gerais, Brazil Hospital Mater Dei, Belo Horizonte, Minas Gerais, Brazil |
54 | Recruiting | Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers | COVID 19 Vaccine | Biological: BCG vaccine | Phase 2 | Universidade Federal do Rio de Janeiro, Ministry of Science and Technology, Brazil | OTHER | 1000 | All | 18 Years | Universidade Federal do Rio de Janeiro, Rio De Janeiro, RJ, Brazil |
53 | Recruiting | Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia | Covid-19 | Drug: Bromhexine Oral Tablet and/or hydroxychloroquine tablet | Phase 4 | General and Teaching Hospital Celje | OTHER | 90 | All | 19 Years | SB Celje, Celje, Slovenia |
52 | Terminated | Use of Convalescent Plasma for COVID-19 | COVID | Biological: Convalescent Plasma | Phase 2 | Northside Hospital, Inc. | OTHER | 7 | All | 18 Years | Northside Hospital, Atlanta, Georgia, United States |